Vyepti (Eptinezumab-jjmr) is a prescription drug approved by the FDA as a preventative treatment for migraines in adults. It is a type of monoclonal antibody called a calcitonin gene-related peptide (CGRP) antagonist, which works by blocking CGRP, a protein that can cause migraine headaches. Vyepti is administered by Show Full Answer

Vyepti (Eptinezumab-jjmr) is a prescription drug approved by the FDA as a preventative treatment for migraines in adults. It is a type of monoclonal antibody called a calcitonin gene-related peptide (CGRP) antagonist, which works by blocking CGRP, a protein that can cause migraine headaches. Vyepti is administered by intravenous (IV) infusion every three months.

Common side effects include:
- Scratchy throat
- Stuffy nose
- Allergic reactions, including skin changes like a rash

Some serious allergic reactions may occur, including swelling of the skin.

For more details, you can visit the following resources:
- [Vyepti — Lundbeck](https://www.vyepti.com)
- [Eptinezumab-jjmr Injection — Medline Plus](https://medlineplus.gov/druginfo/meds/a620022.html)

If you have any personal experiences or questions about Vyepti, it might be helpful to connect with others on platforms like MyMigraineTeam, where members share their stories and advice.

 This AI-generated response comes from MyMigraineTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Vyepti (Eptinezumab-jjmr) for Migraine | MyMigraineTeam

How Does Migraine Infusion Therapy Work? 6 Things To Know | MyMigraineTeam